Dr. Doroshow on Increasing Patient Accrual to Clinical Trials During the COVID-19 Pandemic
James H. Doroshow, MD, discusses strategies that were implemented to increase patient accrual to clinical trials during the COVID-19 pandemic.
Dr. Doroshow on the Importance of Modernizing Clinical Trials After COVID-19
James H. Doroshow, MD, discusses the importance of modernizing clinical trials in the post–COVID-19 era.
Dr Berkenstock on ADC-Related Ocular Toxicities in Cervical and Ovarian Cancers
Dr Matalonis on the Management of Mirvetuximab Soravtansine-Related Toxicities in FRα+ Ovarian Cancer
Updated EMPOWER-Lung 3 Data Support Frontline Cemiplimab Plus Chemo in Advanced NSCLC
Neoadjuvant Nivolumab Plus Chemotherapy Retains EFS Advantage in Resectable NSCLC
2 Clarke Drive Cranbury, NJ 08512